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Muscles exposed to unaccustomed exercise or injurious contractile activities are likely to 
sustain mechanical damage to muscle fibers, a characteristic of contraction-induced 
injuries. The susceptibility of muscles to contraction-induced injury increases with age, 
disuse or disease. Although lesions in the sarcolemma have been implicated in the injury 
process, the conditions that lead to the formation of such lesions, as well as the extent to 
which these lesions affect muscle function remain inadequately understood. To study 
membrane-based events reliably, we developed a micro-sized whole muscle model that 
was robust, but more importantly, compatible with the contemporary techniques used to 
study cellular function. In characterizing this muscle model in vitro, we report a level of 
stability and flexibility that had not been observed in previous whole muscle 
preparations. Utilizing this muscle model, we demonstrated that sarcolemmal lesions and 
overactive mechanosensitive ion channels accounted for the majority of the functional 
deficit observed in the diseased muscles of mdx mice, the murine model of Duchenne 
Muscular Dystrophy. These results provide a basis for the development of therapeutic 
strategies directed at stabilizing the membrane of dystrophic skeletal muscle. When wild-
type muscles were subjected to an injurious protocol of lengthening contractions, the 
mechanical stress associated with lengthening contractions, while severe enough to cause 
 vi
a 30% force deficit, was found to be insufficient to elicit membrane lesions in a whole 
skeletal muscle. This finding diminished the role of mechanical stress as the direct cause 
of sarcolemmal injury and implies that contraction-induced lesions observed in wild-type 
muscle are likely to result from the contributions of other factors, such as reactive oxygen 








The human body contains approximately 630 skeletal muscles, accounting for 
~40% of its mass (17). Skeletal muscles are capable of generating a wide diversity of 
forces and power that provide an extraordinary range of movements. The musculature in 
the lower limbs propel a sprinter to the finish line at a remarkable velocity, whereas the 
muscles in the palm of the hand enable a pianist to play the most delicate of concertos. 
For these reasons, a variety of scholars throughout history have demonstrated a high level 
of interest in muscle structure and function. Indeed, the earliest recorded scientific study 
of muscle function was undertaken by Claudius Galen (129-201 A.D.) over two thousand 
years ago. A physician to the Roman gladiators, Galen performed numerous dissections 
and experiments on animals and was the first to report on the basic function of muscles, 
nerves and vasculature. 
The current understanding of muscle function has increased immeasurably since 
Galen’s rudimentary experiments two millennia ago. Modern textbooks describe in 
remarkable detail the molecular mechanisms, mechanics and energy requirements for 
muscle activity (33). Muscle research continues to expand, fueled by technological 
breakthroughs in computing, imaging, mathematical modeling and genetics. Investigators 
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now have the scientific expertise to measure forces of single myosin molecules (14), 
deliver gene therapies to dystrophic mice (18) and simulate the behavior of muscles 
entirely in silico* (39). Each of these achievements highlights the diverse 
accomplishments made in the pursuit of new knowledge regarding skeletal muscle 
structure and function. 
 
Research Motivation and Approach 
Injury to skeletal muscle fibers occurs as a result of trauma, disease, extreme 
temperature or exposure to myotoxins (6). Despite the potential for these interventions to 
cause injury, muscles most commonly sustain injuries resulting from exercise or 
contractile activity (35). This type of injury, termed a “contraction-induced injury”, is 
characterized by mechanical damage to force-generating components within muscle 
fibers that result in muscle soreness and an impaired ability of the muscle to generate 
force (11). While considerable progress has been achieved in this area of muscle 
research, the causal mechanisms of contraction-induced injuries remain incompletely 
understood. Advancements in the understanding of contraction-induced injuries can 
potentially exert an immediate impact across a wide variety of health issues, including 
muscular dystrophy and age-related muscle weakness of the elderly (4; 31). Patients that 
suffer from muscular dystrophy, as well as individuals from the elderly population, 
exhibit a pronounced susceptibility to contraction-induced injury (12; 57) and are 
consequently obliged to lead sedentary lifestyles. In addition to diminishing the quality of 
                                                 
* An expression used to mean "performed on computer or via computer simulation." 
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life, muscle-associated health issues also exert a substantial  financial burden, estimated 
at ~$15 billion annually from age-related muscle weakness alone (25). 
Due to its complexity, the study of contraction-induced injury may be approached 
from a variety of perspectives. The research presented in this dissertation has focused 
specifically on the role of the plasma membrane in contraction-induced injuries. A 
membrane-based approach offers two distinct advantages. Firstly, potential therapeutics 
developed to target the membrane can exert their effects external to the cell, without a 
need for entry into the cytosol. This is advantageous from a drug delivery standpoint, as 
membrane-targeting drugs can bypass the complicated packaging techniques required for 
cellular uptake (27). Secondly, the elucidation of membrane-based events in a 
contraction-induced injury enables the development of treatment strategies aimed at 
stabilizing the injury-prone membranes of dystrophic muscle (38; 43). To provide a 
background for the research presented in subsequent chapters, a review of select areas of 
muscle function and physiology will be presented in the remaining portion of this 
introductory chapter. 
 
The structure and function of skeletal muscles 
Skeletal muscles consist of numerous cylindrical-shaped cells, known as muscle 
fibers, arranged parallel to one another. Depending on the organism and specific muscle, 
the number of muscle fibers in a whole skeletal muscle range from several hundred to 
several million (13). Each muscle fiber is a fully autonomous cell that contains highly 
specialized structures for force production. The fundamental basis of force generation is 
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derived from the interaction between two major sets of contractile proteins, the actin and 
myosin filaments (23). Spatially, each myosin filament is interdigitated with a hexagonal 
lattice of actin filaments; the overlap of actin and myosin filaments gives muscle its 
characteristic striated appearance (Fig 1.1). Surrounding these filaments is the 
sarcoplasmic reticulum (SR), an extensive membranous network that stores, releases and 
sequesters Ca2+ (2). During periods of quiescence, the basal concentration of intracellular 
Ca2+ is insufficient to elicit any interaction between actin and myosin filaments. When an 
action potential arrives at the muscle fiber, ion channels on the SR release Ca2+ into the 
cytosol that cause the concentration of Ca2+ in the myoplasm to increase ~ 200 fold (19). 
The Ca2+ exposes myosin-specific binding sites on the actin filaments that allow the two 
filaments to bind strongly to one another and form multiple cross-bridges. The movement 
of cross-bridges and their subsequent dissociation constitute the basis of the force-
generating mechanism known as the cross bridge cycle (16) (Fig 1.2). Depending on the 
magnitude of the external load and the forces developed by the muscle fibers, contracting 
muscle fibers may either shorten, remain isometric, or lengthen (11). 
In addition to the contractile apparatus, each muscle fiber is surrounded by an 
extensive network of supportive proteins and collagenous connective tissue (55) 
collectively known as the extracellular matrix (ECM). The ECM has three levels of 
organization; an endomysium that surrounds individual muscle fibers, a perimysium that 
encloses bundles of muscle fibers, and the epimysium that encompasses the entire muscle 
(49). The ECM transmits the forces generated by muscle fibers to the tendon as well as to 
adjacent muscle fibers (28; 46). Accordingly, the ECM can be regarded as a functional 
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link between muscle fibers and the skeleton (28). Mutations to proteins of the ECM result 
in two specific forms of muscular dystrophy, Congenital and Bethlem (8; 26), that 
highlight the importance of the ECM to muscle function. 
 
The sarcolemma: the plasma membrane of muscle fibers 
Fundamentally, cellular membranes serve as barriers to isolate cytosolic contents 
from the extracellular space.  Through a finely-tuned system of channels, pumps and 
receptors, plasma membranes continuously regulate the concentration of ions in the 
cytosol to maintain an environment conducive for cellular processes (53; 56). In this 
regard, the sarcolemma behaves in a similar manner to that of the membranes of other 
eukaryotic cells. Indeed, several regulatory ion channels in the sarcolemma have 
homologous counterparts in the membranes of other cell types (42; 61). The mechanical 
properties of the sarcolemma are also similar to the membranes of other cell types and 
even artificial lipid bilayers (9; 10; 40). The functional resilience of the sarcolemma to 
mechanical stress is largely attributable to specialized protein complexes that are 
embedded periodically along the membrane of muscle fibers (3). These protein 
complexes, otherwise known as dystrophin-associated glycoprotein complexes (DGC), 
serve as membrane-bound connectors that link the contractile apparatus to ECM (3). 
These linkages impart mechanical stability to the sarcolemma by protecting it from the 




Characterization of a contraction-induced injury 
Following unaccustomed physical activity, individuals commonly experience a 
delayed-onset of muscle soreness (DOMS), a phenomenon first recognized over a century 
ago (20). DOMS is indicative of a contraction-induced injury, with muscle soreness often 
accompanied by swelling (21) and efflux of intracellular enzymes from muscle fibers 
(50). Compared with shortening or isometric contractions, lengthening contractions are 
the only type of contractions that reproducibly causes injury in muscles (30; 36). The 
force deficit immediately after a severe, exhaustive protocol of lengthening contractions 
is attributable to both fatigue and injury, with the recovery from fatigue complete by ~3 
hours (11). Depending on the severity of the contraction protocol, complete recovery 
from a contraction-induced injury may require durations from several weeks to 30 days 
(47). The overall progression of a contraction-induced injury is characterized by two 
distinct phases: an initial phase of injury ~0-12 hours after the protocol and a more severe 
secondary injury ~2-3 days later (11).  
In the initial phase of a contraction-induced injury, the observed force deficit is 
largely attributable to mechanical damage to the force generating structures of muscle 
fibers (5; 15; 30). Electron micrographs of injured muscle fibers indicate a variety of 
severe ultrastructural abnormalities that include disrupted striation patterns and a 
displacement of actin and myosin filaments (5; 15; 30). In addition to ultrastructural 
damage, other factors also contribute to the initial force deficit, including disruption of 
the excitation-coupling system (54; 59) and activation of proteolytic factors (1). 
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 In contrast to the initial injury, the force deficit in the secondary phase of 
contraction-induced injury is a result of oxidative stress (29; 62). Muscles exhibit overt 
morphological changes during the secondary phase of contraction-induced injury and 
portions of fibers at various stages of degeneration can be observed with conventional 
light microscopy (62). In severely damaged muscle fibers,  a sealing-off process occurs 
around the site of injury that isolates the damaged region from the intact portions of the 
muscle fiber (36; 48). This sealing-off process ensures that only sufficiently damaged 
regions of the injured muscle fiber undergo repair. The sealed-off region gradually 
becomes contiguous with the extracellular space and attracts inflammatory cells that 
breakdown and remove cellular debris (36). Reactive oxygen species released by these 
inflammatory cells cause additional damage to uninjured muscle (45), accounting for the 
increase in force deficit during the secondary phase of contraction-induced injury (36; 
62).  
 
The role of calcium in muscle damage 
Calcium plays a dual role in muscle function, serving as a signaling molecule as 
well as a regulator of muscle contraction and relaxation (2). To effectively regulate 
cytosolic [Ca2+], muscle fibers contain a complex system of channels, pumps and 
buffering proteins, each dedicated to mobilize, transport or sequester Ca2+ (2). A loss of 
Ca2+ homeostasis typically results in an accumulation of cytosolic Ca2+ that damages the 
muscle fiber via Ca2+-activated free radical and enzymatic processes (17). These 
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destructive processes target the cytoskeleton and sarcolemma, and if left unchecked, 
could ultimately result in the necrosis of the entire muscle fiber (17; 52). 
 A loss in Ca2+ homeostasis can be triggered by a variety of interventions 
including hypoxia (34), osmotic stress (24) and prolonged contractile activity (32). The 
increase in resting cytosolic Ca2+ observed after prolonged contractile activity is partially 
attributable to Ca2+ influx through ion channels on the sarcolemma (42; 51). In addition 
to the ion channel pathway, Ca2+ may also enter through contraction-induced lesions in 
the sarcolemma (37; 41; 44). Presently, the mechanisms responsible for these 
contraction-induced lesions are still unclear, although mechanical stress has been 
proposed to play an important role (37; 41; 58). These lesions are likely to be significant 
contributors to the contraction-induced elevation of cytosolic Ca2+, given the ~18,000 
fold difference in Ca2+ concentration that exists across the membrane of quiescent muscle 
fibers (60).  
 
Aims 
The overall aim of this dissertation was to determine, in whole skeletal muscles, 
the contribution of discrete membrane lesions to contraction-induced injury, and in 
addition, examine the conditions that promote the formation of these lesions. All 
experiments were performed on a micro-sized whole muscle preparation that utilizes the 
lumbrical (LMB) muscle from the forepaw of a mouse. This miniature muscle model was 
largely based on the hindpaw LMB preparation developed previously by Claflin and 
Brooks (7). 
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To address the aims of the dissertation, three studies were performed and the 
results presented in chapters 2, 3 and 4, respectively. The goal of the first study was to 
characterize the LMB muscle from the forepaw and assess its potential as a model to 
study contractile activity. The second study utilized a membrane-patching polymer to 
determine the contribution of sarcolemmal lesions to the contraction-induced force 
deficits of dystrophic muscle. Results from this work motivated the development of the 
final study that sought to determine the extent to which contraction-induced lesions 





Figure 1.1. Spatial orientation of actin and myosin filaments. Top: Each myosin filament 
is interdigitated with a two hexagonal arrays of actin filaments. One end of each actin 
filament is attached directly to the Z-disc, a network of interconnecting proteins. Myosin 
filaments are attached to the Z-disc at both ends via a set of elastic proteins (not shown). 
Bottom: The movement of actin filaments towards the center of the myosin protein results 
in the contraction of muscle. 
 10
 
Figure 1.2. The cross bridge cycle. The cycle is initiated when the myosin head attaches 
to the actin filament (1→2). In the next phase, the myosin head pulls the actin filament, 
releasing ADP and inorganic phosphate in the process (2→3). The dissociation of the 
myosin head from the actin filament is induced by binding an ATP molecule (4). The 
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The benefits of a miniature whole muscle model for studies of prolonged, repetitive 
contractile activity in vitro 
 
Abstract 
Whole muscle preparations offer uncomplicated and reliable models for the study 
of muscle function in vitro. Despite their utility, whole muscle models such as the soleus 
or EDL muscle frequently remain too large for the application of contemporary imaging 
techniques. In addition, these muscles require long and often uncertain incubation periods 
for the equilibration of externally-applied macromolecular compounds. In the present 
study, we describe the development of an extremely small whole muscle preparation that 
overcomes the traditional limitations associated with whole muscle models. This 
miniature muscle preparation utilizes the lumbrical muscle (LMB) from the forepaw of 
the mouse that has a cross sectional area ~1/25th that of an EDL muscle. When subjected 
to a protocol of 900 isometric contractions, the LMB muscles maintained force 
production throughout a 30 min test period and showed no signs of fatigue, or 
deterioration. In contrast, when LMB muscles were subjected to 900 lengthening 
contractions, a 20% post-protocol force deficit occurred with overt damage to individual 
muscle fibers. The injury was easily visualized with Evans Blue Dye, while the muscle 
remained in vitro. In addition to force deficit measurements, quantification of muscle 
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damage was achieved through fluorescence measurements of FM1-43. Overall, the LMB 
muscles proved to be: (i) compatible with fluorescence techniques, (ii) sufficiently small 
to enhance the diffusion of macromolecules and (iii) stable even under severe metabolic 
demands. These features qualify the LMB muscle as a flexible and robust model for the 
study of prolonged contractile activity in vitro. 
 
Introduction 
The consistency, flexibility and overall control that the investigator has over in 
vitro muscle preparations has resulted in such muscle models becoming commonplace in 
many laboratories. In vitro models of mature skeletal muscles generally utilize either 
single muscle fibers (10; 15), or whole muscles (2), with each model possessing a distinct 
set of strengths and weaknesses. Compared with single muscle fibers, whole muscle 
models are easier to prepare in terms of the sophistication of the dissection required and 
offer a more accurate representation of physiological responses of muscles functioning in 
vivo. Despite these advantages, most whole muscle models are bulky and consequently 
require long and often uncertain incubation periods with dyes (7; 23), or macromolecular 
compounds. In addition, the large sizes of whole muscle models exclude the practical use 
of live cell fluorescence microscopy, a technique that is now utilized routinely in many 
areas of biological research (12; 17). The incompatibility of large whole muscles with 




Recognizing the potential research impact that could be achieved from the 
miniaturization of whole muscle models, we developed a micro-sized whole muscle 
preparation that utilizes the lumbrical (LMB) muscle located in the fore-paw of a mouse. 
LMB muscles possess a cross-sectional area ~1/25th that of the extensor digitorum longus 
(EDL) muscle (4) and, by virtue of their small size, is able to retain much of the diffusion 
visualization benefits associated with single muscle fiber preparations. We have 
demonstrated previously the compatibility of LMB muscles with fluorescence techniques 
(5), as well as their effectiveness in incorporating macromolecular compounds (19). The 
purpose of the present study was to characterize the LMB muscle preparation based on an 
assessment of its potential as a model for the study of prolonged contractile activity in 
vitro. LMB muscles were divided into two groups and subjected to a protocol of either 
900 isometric or 900 lengthening contractions over a 30 min test period. Injury to LMB 
muscles was assessed by force measurements, as well as visualization with Evans Blue 
Dye and fluorescent indicator FM1-43, a lipophilic, membrane-impermeable dye that 
fluoresces when partitioned into membranes (6). 
 
Methods 
Specific-pathogen-free male C57BL/6 mice 7-15 months of age were obtained 
from the Jackson Laboratory (Bar Harbor, ME). Mice were housed in a specific-
pathogen-free barrier facility at the University of Michigan. All experimental procedures 
were approved by the University of Michigan Committee on the Use and Care of Animals 
and in accordance with the Guide for the Care and Use of Laboratory Animals [DHHS 
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Publication No. 85–23 (NIH), Revised 1985, Office of Science and Health Reports, 
Bethesda, MD 20892]. 
 
Operative procedure  
Mice were anesthetized with an intraperitoneal injection of Avertin 
(tribromoethanol 400mg/kg). Supplemental doses of Avertin were administered as 
required to keep the mouse unresponsive to tactile stimuli.  The front paws were severed 
from the mice and the lumbrical (LMB) muscles dissected free from the third digit. The 
mice were subsequently euthanized by an overdose of Avertin followed by a 
thoracotomy. Dissections were performed in a chilled bathing solution (approx. 8°C), 
with a composition in mM of: 137 NaCl, 11.9 NaHCO3, 5.0 KCl, 1.8 CaCl2, 0.5 MgCl2, 
0.4 NaH2PO4. The isolated LMB muscle was mounted horizontally in a custom-
fabricated chamber with the distal tendon attached to a force transducer (Aurora 
Scientific, Inc., modified Model 400A) and the proximal tendon to a servomotor (Aurora 
Scientific, Inc., Model 318B). The ties were composed of 10-0 monofilament nylon 
suture. Bath temperature was maintained at 25°C and the chamber was perfused 
continuously with Tyrode solution, with a composition in mM of: 121 NaCl, 24 NaHCO3, 
5.0 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 NaH2PO4. A pH of 7.3 was maintained by bubbling 
with a gas mixture of 95% O2 and 5% CO2.  
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Contractility measurements and contraction protocol 
Muscles were stimulated electrically by current passed between two platinum 
plate electrodes. The constant-current stimulation pulses were 0.5 ms in duration and 
their magnitude was adjusted to elicit a maximum twitch response. Optimum length (Lo) 
of each muscle was determined by adjusting muscle length until maximum twitch force 
was attained. LMB muscles were sufficiently small that individual fibres could be 
discerned, allowing the length of muscle fibres (Lf) to be determined visually when the 
muscle was at Lo. To achieve a maximum isometric tetanic contraction, the muscle was 
stimulated with supramaximal intensity and frequency using pulses of alternating 
polarity. The specific force of each LMB muscle was calculated by dividing the 
maximum isometric force by an average cross-sectional area of 0.049 m2, a value 
obtained from the estimation of the diameter of four LMB muscles (with the assumption 
of a circular cross-section). 
To simulate prolonged contractile activity in vitro, LMB muscles were divided 
into two groups and subjected to either 900 isometric (IC, n=4), or 900 lengthening (LC, 
n=8) contractions. Each contraction was 100 ms in duration and spaced at 2 s intervals, 
resulting in 30 min of continuous contractile activity. For the lengthening contractions, a 
stretch of 5% Lf was applied 40 ms after the start of stimulation and the muscle was 




Measurements of fluorescence from FM1-43 
Muscles were exposed to FM1-43 (2.5 μM in Tyrodes solution) after cessation of 
the contraction protocol. Fluorescence intensity measurements were collected from an 
area 1.1 mm by 0.23 mm along the length of the muscle and sampled periodically until no 
further increase in fluorescence intensity was noted. This final measurement was assigned 
as the fluorescence value for the muscle. Fluorescence was elicited by epi-illumination 
from a 75 W xenon lamp and detected using a photometer system (Photon Technology 
International, model Deltascan 4000). Excitation wavelength was selected using a 
diffraction grating monochrometer and was centered at 479 nm (bandwidth 2 nm). The 
emitted fluorescence passed through a longpass filter (520 nm) before reaching the 
photomultiplier tube for detection. 
 
Statistics 
Data are presented as a mean value ± SEM. Statistical analyses were performed using 
analysis of variance (ANOVA) with the level of significance set a priori at P < 0.05. 




The absolute and specific forces measured before the contraction protocol began 
were not different for the IC and LC groups. Pooling of the data yielded an average 
absolute force value of 12.1 ± 0.8 mN and a specific force of 247 ± 16 kN/m2 (n=12). 
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Throughout the contraction protocol, muscles in the IC group generated forces that were 
not different from the initial time point (Fig 2.1B). In contrast, muscles in the LC group 
exhibited a rapid decline in force production and yielded a force deficit of ~50% 
immediately after the 900 LC protocol (Fig 2.1B). This force deficit was reduced to 
~20% after a recovery period of 5 min and an additional period of recovery yielded no 
further reduction (Fig 2.1B). The recovery in force observed in the LC group is unlikely 
due to fatigue, as muscles in the IC group shared an identical duty cycle and did not 
demonstrate fatigue. The partial recovery of the force deficit following a non-fatiguing 
lengthening contraction protocol has been reported previously (3), and is not well 
understood. We propose that this partial recovery results from the realignment of 
disrupted contractile proteins. 
 
Physical appearance of LMB muscles following repetitive lengthening contractions 
After the LC protocol, LMB muscles showed overt signs of injury in a 
subpopulation of muscle fibers (Fig 2.2). A ~3 min incubation with Evans Blue Dye 
allowed visualization of the injury, which appeared as regions of myoplasmic separation 
and hypercontracture (Fig 2.2). The basement membrane of these injured muscle fibers 
appeared to remain intact, despite the retraction of large segments within the fiber. 
Injured muscle fibers resembled the “retraction clots” observed in single muscle fibers 
that sustained puncture wounds to the sarcolemma (21; 22). When incubated with FM1-
43, the dye showed strong localization to the hypercontracted regions of muscle fibers 
(Fig 2.2). Due to its lipophilic nature (6), FM1-43 was likely to have bound selectively to 
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the aggregated plasma membranes in these contracture clots. Comparisons between 
muscles from IC and LC groups revealed that muscles in the LC group produced a 




LMB muscles remain viable during prolonged contractile activity in vitro 
The robustness of the LMB muscle was demonstrated by its ability to maintain 
force production throughout the 30 min protocol of 900 isometric contractions. We are 
not aware of any other in vitro muscle preparation that behaves in a comparable manner. 
Typical muscle models, such as the extensor digitorum longus (EDL) muscle, show signs 
of fatigue even under less demanding contraction protocols (18; 19). The enhanced 
stability of the LMB muscle preparation is likely to be attributed to its small size that 
facilitates the movement of metabolites to and from the core of the muscle. The stability 
of the LMB muscles provides a strong endorsement for the application of this model to 
study repetitive contractile activity, or other aspects of muscle function that require 
prolonged experimentation in vitro (11; 20). 
 
Size-associated benefits of LMB muscles 
LMB muscles were sufficiently small to allow individual muscle fibers to be 
discerned in vitro, which permitted the use of fluorescence techniques to study muscle 
function or, in the case of the present study, assess damage. Utilizing FM1-43, we 
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demonstrated that the damage associated with contraction-induced injuries may be 
quantified by a fluorescence-based assay that provides a useful supplement to force 
deficit measurements. Compared with the measurements of force deficits, fluorescence-
based assays are likely to provide a more specific and sensitive indication of muscle 
damage. The compatibility of LMB muscles with live fluorescence microscopy raises an 
exciting prospect for the application of fluorescent probes to elucidate various aspects of 
muscle function.  
The short diffusion distance associated with LMB muscles is also particularly 
advantageous in experiments that utilize bulky, macromolecular compounds. This is 
because the time required for external compounds to reach the core of the muscle varies 
inversely with the square of its radius (8). This benefit is exemplified by the rapid ~3 min 
equilibration period with Evans Blue Dye; an incubation period that is ~20 times shorter 
than the existing 45-60 min required for whole muscle models such as the EDL or soleus 
(7; 23).  
 
Comparison with in vivo models of repetitive contractile activity 
As a means to validate the LMB muscle model, we compared the extent of 
damage observed in LMB muscles with those induced by downhill running exercise, a 
method used frequently to administer repetitive lengthening contractions to skeletal 
muscles of rodents (1; 13; 14; 16). Histological examination of muscles injured by 
downhill running exercises reveal an extent of damage that is less severe compared with 
the present protocol of repetitive lengthening contractions administered in vitro (1; 13; 
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16). We attribute this disparity to the milder forms of contractile activity associated with 
voluntary downhill running protocols. Muscles are activated sub-maximally during 
voluntary exercise, with recruitment of only a small proportion of the total motor units 
present in the muscle (9).  The conditions in vitro are more severe, as all muscle fibers 
are activated maximally during each contraction for the entire duration of the exercise 
period. These differences are likely to account for the increased instances of overt 
damage to muscle fibers observed in the present study. 
 
Conclusion 
While the scope of the present study has been limited to contraction-induced 
injury, we are confident that the utility of the LMB muscle preparation can be extended to 
study almost all aspects of muscle research. We have established this unique micro-sized 
muscle preparation to be: (i) compatible with fluorescence techniques (ii) sufficiently 
small to promote the diffusion of dyes and macromolecules (19), and (iii) stable even 
during rigorous contractile protocols. 
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Fig 2.1 Force production of LMB muscles. Top: Example record of a typical force trace 
shown alongside stimulation and lengthening parameters. For clarity, only units of force 
is represented. Bottom: Force production during a 30 min protocol of 900 contractions. IC 
and LC denote isometric and lengthening contractions, respectively. Muscles in the IC 
group generated forces that were not different from the initial time point (Power > 0.8). 
Muscles in the LC group exhibited a force deficit of ~50% immediately after the 
lengthening contraction protocol that recovered to ~20% after a recovery period. Break 
along x-axis denotes the cessation of contractile activity. * indicates a difference when 




Fig 2.2.  Visualization of injured muscle fibers with Evans Blue Dye (4.6μM, ~3 min 
incubation, panels A-C) and FM1-43 (panel D). Images were captured using a digital still 
camera and brightness/contrast modifications made using image editing software. (A) 
LMB muscle after a protocol of 900 isometric contractions. (B) LMB muscle after 900 
lengthening contractions. Muscle exhibits overt injury to individual muscle fibers clearly 
visualized by Evans Blue Dye. Scale bar is 300μm. (C) Close up of a damaged muscle 
fiber showing regions of myoplasmic separation. Note that the basement membrane still 
appears intact, and also the presence of striation patterns in adjacent, uninjured muscle 
fibers. (D) Brightfield image of LMB muscle after lengthening contractions 
superimposed with a fluorescent image of lipophilic dye FM1-43. Images reveal a 





























Fig 2.3.  Measurements of FM1-43 intensity in muscles from IC and LC groups. LMB 
muscles were incubated with FM1-43 (2.5μM) after a protocol of either 900 isometric 
(IC) or lengthening contractions (LC). Fluorescence intensity measurements were 
collected from an area 1.1 mm by 0.23 mm along the length of the muscle. * indicates a 
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Poloxamer 188 reduces the contraction-induced force decline in lumbrical muscles 
from mdx mice 
 
Abstract 
Duchenne Muscular Dystrophy is a genetic disease caused by the lack of the 
protein dystrophin. Dystrophic muscles are highly susceptible to contraction-induced 
injury, and following contractile activity, have disrupted plasma membranes that allow 
leakage of calcium ions into muscle fibers. Because of the direct relationship between 
increased intracellular calcium concentration and muscle dysfunction, therapeutic 
outcomes may be achieved through the identification and restriction of calcium influx 
pathways. Our purpose was to determine the contribution of sarcolemmal lesions to the 
force deficits caused by contraction-induced injury in dystrophic skeletal muscles. Using 
isolated lumbrical muscles from dystrophic (mdx) mice, we demonstrate for the first time 
that P188, a membrane sealing poloxamer, is effective in reducing the force deficit in a 
whole mdx skeletal muscle. A reduction in force deficit was also observed in mdx 
muscles that were exposed to a calcium-free environment. These results, coupled with 
previous observations of calcium entry into mdx muscle fibers during a similar 
contraction protocol, support the interpretation that extracellular calcium enters through 
sarcolemmal lesions and contributes to the force deficit observed in mdx muscles. The 
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results provide a basis for potential therapeutic strategies directed at membrane 
stabilization of dystrophin-deficient skeletal muscle fibers. 
 
Introduction 
Duchenne Muscular Dystrophy (DMD) is an X-linked genetic disease caused by a 
mutation in the dystrophin gene. As a result, muscles from patients with DMD lack 
dystrophin, a 427 kDa protein located beneath the cytoplasmic surface of the plasma 
membrane, the sarcolemma, of muscle fibers (5).  Dystrophin is required for the assembly 
of the dystrophin-associated glycoprotein complex that is embedded in the sarcolemma 
(26).  The dystrophin-glycoprotein complex links the actin cytoskeleton to the basement 
membrane and is thought to provide mechanical stability to the sarcolemma (19; 28). 
Although the exact function of dystrophin is still unknown, the pathology demonstrated 
by skeletal muscles of young males that lack dystrophin is dramatic. Boys with DMD 
experience progressive muscle weakness beginning at about 2-5 years of age, are 
wheelchair bound by age 12, and die in their mid-twenties from respiratory or cardiac 
failure (17). 
The mdx mouse, discovered in 1984 (9), does not express dystrophin and 
consequently provides an important animal model for studying the effects of dystrophin 
deficiency. Studies performed on muscles from the mdx mouse, hereafter termed mdx 
muscles, have documented impairments in structure and function, including a high 
susceptibility to contraction-induced injury (11; 15; 21). We have shown previously that 
force deficits produced by contraction-induced injury to mdx muscles are associated with 
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an influx of extracellular calcium into muscle fibers (11). Stretch-activated, store-
operated and calcium leak channels have been implicated as entry sites responsible for 
the influx of extracellular calcium (6; 13; 35). However, these ion channels are unlikely 
to be entirely responsible for the calcium influx since bulky, membrane impermeable 
dyes and enzymes also traverse the sarcolemma of dystrophic muscles (1; 29; 30). These 
observations suggest the involvement of larger, nonspecific calcium entry pathways in 
the membrane, such as sarcolemmal lesions. 
  Poloxamer 188 (P188) is an 8.4 kDa amphiphilic polymer that localizes into lipid 
monolayers (33) and damaged portions of membranes (22). When applied to injured 
cells, P188 repairs disrupted membranes and enhances the recovery of skeletal muscle 
(20), fibroblasts (25), cardiac myocytes (34) and the spinal cord (7) from a variety of 
injury-inducing protocols. Our purpose was to determine, through the application of 
P188, the extent to which sarcolemmal lesions are responsible for the increased 
susceptibility of dystrophic skeletal muscles to contraction-induced injury. To minimize 
concerns regarding non-uniform intramuscular distribution of the applied compounds, we 
utilized the lumbrical (LMB) muscle, a very small whole muscle located in the forepaw 
of the mouse. LMB muscles were treated with P188 and then subjected to an isometric 
contraction protocol in vitro that produced a force deficit in untreated mdx muscles. We 
hypothesized that the force deficits would be highest in untreated dystrophic muscles, 





Specific-pathogen-free male mdx mice (C57BL/10ScSn-mdx stock #001801) 2-3 
months of age and wild-type (WT) C57BL/10 mice 2-5 months of age were obtained 
from the Jackson Laboratory (Bar Harbor, ME).  Mice were housed in a specific-
pathogen-free barrier facility at the University of Michigan. All experimental procedures 
were approved by the University of Michigan Committee on the Use and Care of Animals 
and in accordance with the Guide for the Care and Use of Laboratory Animals [DHHS 
Publication No. 85–23 (NIH), Revised 1985, Office of Science and Health Reports, 
Bethesda, MD 20892]. 
 
LMB muscle as a model to study contraction-induced injury in vitro 
The use of a small muscle such as the LMB minimizes the demands made on 
diffusion processes that may arise when using a larger whole muscle. The shorter 
diffusion paths of the small muscle facilitate the movement of metabolites to and from its 
core, maintaining its viability in vitro. Throughout the course of the experiments, LMB 
muscles of WT mice exhibited a sustained ability to maintain force, a positive indication 
of the overall stability of the muscle. The initial experimental design included a parallel 
set of experiments on the more commonly used extensor digitorum longus muscle (EDL). 
During these experiments, the EDL exhibited fatigue, with a ~10% loss in force after 10 
isometric contractions followed by a full recovery of force after a rest period of 10 min 
(see Supplementary Materials). Since our goal was to investigate contraction-induced 
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injury in the absence of confounding factors such as loss of force due to fatigue, the 
experiments on the EDL muscles were discontinued. 
 The shorter diffusion distance associated with small muscles is also advantageous 
in drug-based experiments, particularly when macromolecules such as P188 are tested. 
This is because the time required for the concentration of a compound at the core of the 
muscle to reach 50% of its concentration in the bathing medium is proportional to the 
square of the radius of the muscle (16). For example, the LMB muscle with a typical 
radius of 150μm would require a diffusion time that is 16-fold less than the EDL muscle 
that has a typical radius of 600μm (10). 
Intact single muscle fibers circumvent diffusion-based problems and have been 
used to study the effects of membrane-targeting compounds in mdx muscles (35). Despite 
advantages for drug distribution, the behavior of an isolated single muscle fiber without 
interactions with adjacent muscle fibers might not provide an accurate representation of 
the function of a whole muscle. A small whole muscle such as the LMB retains some of 
the diffusion benefits and visualization advantages normally accorded to single muscle 
fiber preparations, while maintaining a more accurate representation of in vivo whole 
muscle function.  
 
Operative procedure  
Mice were anesthetized with an intraperitoneal injection of Avertin 
(tribromoethanol 400mg/kg). Supplemental doses of Avertin were administered as 
required to keep the mouse unresponsive to tactile stimuli.  The front paws were severed 
  43
 
from the mice and the LMB muscles dissected free from the third digit. The mice were 
subsequently euthanized by an overdose of Avertin followed by a thoracotomy. 
Dissections were performed in a chilled bathing solution (approx. 8°C), composition in 
mM: 137 NaCl, 11.9 NaHCO3, 5.0 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 NaH2PO4. Based on 
physical dimensions, LMB muscle mass was estimated to be approximately 0.2 mg. The 
isolated LMB muscle was mounted horizontally in a custom-fabricated chamber with the 
distal tendon attached to a force transducer (Aurora Scientific, Inc., modified Model 
400A) and the proximal tendon to a servomotor (Aurora Scientific, Inc., Model 318B). 
The ties were composed of 10-0 monofilament nylon suture. Bath temperature was 
maintained at 25oC and the chamber was perfused continuously with Tyrode solution 
(composition in mM: 121 NaCl, 24 NaHCO3, 5.0 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 
NaH2PO4). A pH of 7.3 was maintained by bubbling with a 95%/5% O2/CO2 mixture. 
 
Isometric contraction protocol 
LMB muscles were stimulated electrically by current passed between two 
platinum plate electrodes. The constant-current stimulation pulses were 0.5 ms in 
duration and their magnitude was adjusted to elicit a maximum twitch response. 
Optimum length (Lo) of each muscle was determined by adjusting muscle length until 
maximum twitch force was attained. To achieve a maximum isometric tetanic 
contraction, the muscle was stimulated with supramaximal intensity and frequency using 
pulses of alternating polarity. The protocol used to induce a force deficit consisted of 20 
maximum isometric contractions, each lasting 1 second and separated by 1 minute. The 
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one minute rest period between contractions was necessary to eliminate fatigue, thereby 
ensuring that any decline in the force generating capability of the muscles during and 
after the 20 contractions was attributable to contraction-induced injury. To facilitate 
comparisons among groups of muscles that varied in mass, the absolute isometric force of 
each muscle during the contraction protocol was normalized to the maximum isometric 
force (Po) produced by the muscle during the 20-contraction protocol. 
 
Treatment groups 
LMB muscles from WT mice were divided into two groups. One group was 
exposed to normal Tyrode solution and the other group to a nominally calcium-free 
Tyrode solution. LMB muscles from mdx mice were divided into 5 groups according to 
their treatment with: (i) P188, (ii) streptomycin, (iii) P188 and streptomycin, (iv) 
nominally calcium-free Tyrode, or (v) normal Tyrode. Streptomycin is an of inhibitor 
stretch-activated channels that reduces the magnitude of the contraction-induced force 
deficits in EDL muscles from mdx mice (32; 35). Experiments with streptomycin were 
included in the present study to validate the relatively novel LMB muscle preparation. 
Concentrations of P188 (Bayer, NJ) and streptomycin (Sigma, #S1277) in Tyrode 
solution were 1 mM and 200 μM, respectively. For all treatments, muscles were allowed 
to incubate in the chamber for 15 minutes prior to commencement of the contraction 
protocol. Pilot experiments performed on WT muscles exposed to P188 (1 mM) or 
streptomycin (200 μM) indicated that these compounds caused no decline in the Po of the 
muscles when used at these concentrations. For nominally calcium-free experiments, 
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CaCl2 was omitted from the Tyrode solution and MgCl2 was increased to 2.3 mM to 
maintain the concentration of divalent cations.  
Force deficits that arise from calcium-free experiments have two potential origins: 
a contraction-induced force deficit and an “environmental” force deficit caused by 
prolonged exposure of the muscle to a non-physiological environment. To separate the 
contraction-induced from the environmental force deficit, we assumed that the calcium-
free environment had an effect that was equally deleterious to both WT and mdx muscles 
and consequently normalized the force responses of mdx muscles in calcium-free 
environments to those of WT muscles in the same calcium-free environments. At the end 
of the contraction protocol, isometric tetanic force of mdx muscles, expressed as a 
percentage of Po, was divided by the isometric tetanic force of WT muscles, also 
expressed as a percentage of Po. This procedure for the normalization of the data isolated 
the contraction-induced force deficits, allowing comparisons between the mdx muscles in 
calcium-free and normal environments.  
 
Statistics 
Data are presented as a mean value ± SEM. Statistical analyses were performed 
using analysis of variance (ANOVA) with the level of significance set a priori at P < 





Histology and isometric force production 
LMB muscles were approximately 300 μm in diameter and consisted of 200 to 
250 fibers (Fig 3.1A, B). Cross-sections from mdx muscles displayed typical dystrophic 
features (8) including areas of mononuclear cell infiltration and a population of fibers 
with central nuclei (Fig. 1C). The mean absolute Po of untreated mdx muscles (10.8 ± 0.4 
mN, n=8) was less than that of WT muscles (14.8 ± 0.9 mN, n=6). Treatment of mdx 
muscles with streptomycin, or P188, or with both streptomycin and P188 simultaneously, 
did not affect the absolute Po (data not shown). In the nominally calcium-free Tyrode 
solution, the absolute Po of both WT and mdx muscles decreased by ~30% to 10.8 ± 0.5 
mN (n=3) and 7.2 ± 1.3mN (n=4), respectively. This decrease in force is likely due to an 
impairment in the excitation-contraction coupling process caused by removal of calcium 
from the extracellular buffer (18).  
 
Force production of WT and mdx muscles during the contraction protocol 
Forces generated by LMB muscles from WT mice remained constant throughout 
the contraction protocol with no signs of fatigue or injury (Fig 3.2A & B). In contrast, 
untreated mdx muscles displayed a steady decline in force production as the protocol 
progressed (Fig 3.2B). Comparisons between mdx and WT muscles at individual 
contraction intervals revealed differences between the two genotypes for each contraction 
after the 7th. After a recovery period of 10 minutes, the magnitude of force was 
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unchanged, indicating that the force deficits observed in mdx LMB muscles were not 
caused by muscle fatigue but by contraction-induced injury (8). 
 
Effects of P188 and streptomycin 
At the end of the isometric contraction protocol, normalized force values were 
highest in the WT group and lowest in the untreated mdx group, at 98% and 69% of Po, 
respectively (Fig 3.3). The mdx muscles in the P188+streptomycin group and in the 
calcium-free group generated normalized forces that were not different from muscles in 
the WT group (Fig 3.3). Treatment of mdx muscles with either P188 or streptomycin 
alone resulted in force values that were intermediate between the untreated mdx group 
and the WT group (Fig 3.3). 
 
Discussion  
The increased potential for permeability of the sarcolemma of dystrophic muscle 
fibers to extracellular calcium is likely to contribute to the increased susceptibility of 
dystrophic fibers to contraction-induced injury. In agreement with this hypothesis, we 
have shown previously that during a contraction protocol similar to the one used here, the 
contraction-induced mechanical failure of LMB muscles from the hindpaw of mdx mice 
was largely attributable to the influx of extracellular calcium into muscle fibers (11). 
Because of the direct relationship between increased intracellular calcium concentration 
and muscle dysfunction (3; 12; 31), therapeutic outcomes may be achieved through the 
identification and restriction of calcium influx pathways. In the present study, we confirm 
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that stretch-activated channels (SAC) (32; 35) are one such pathway and report the 
additional involvement of sarcolemmal lesions as contributors to contraction-induced 
force deficit in mdx skeletal muscles. 
Previous studies have established P188 as a membrane-patching polymer that 
interacts directly with monolayers (33) and disrupted membranes (22). P188 is effective 
in stabilizing membranes and enhances the recovery of a variety of cell types from an 
array of injury-inducing protocols (7; 20; 25; 34). In the present study, P188 reduced the 
contraction-induced force deficit in mdx muscles by approximately 50% (Fig 3.3). A 
reduction in force deficit was also observed in mdx muscles that were exposed to a 
calcium-free environment. These results, coupled with a direct observation of calcium 
entry into dystrophic LMB muscle fibers during a similar contraction protocol (11), 
support the interpretation that the contraction protocol used in the present study results in 
sarcolemmal lesions that allow an influx of extracellular calcium, and that these entry 
pathways contribute significantly to the magnitude of the force deficit observed in mdx 
muscles. Despite the evidence of sarcolemmal lesions in mdx muscles, the mechanisms 
responsible for their formation remain uncertain. Given the vulnerability of the 
dystrophin-deficient sarcolemma (24; 27), lesions could have arisen from mechanical 
stress associated with contractile activity (23; 29), or alternatively, sarcolemmal lesions 
could result as a secondary consequence of Ca2+ entry into the muscle fibers (32). In this 
scenario, excessive influx of Ca2+ triggers the activity of lipid-damaging pathways (14) 
that induce lesions in the sarcolemma. 
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A treatment that combined both P188 and streptomycin produced only a marginal 
improvement over singly treated mdx muscles (Fig 3.3). The lack of a clear additive 
effect when P188 and streptomycin were used together suggests that, while both SAC and 
membrane lesions contribute to increased intracellular calcium, blockage of either 
pathway alone is sufficient to reduce the magnitude of the observed force deficit. Several 
potential explanations could account for this observation. One possibility is that the 
magnitude of calcium influx through either SAC or membrane lesions alone does not 
exceed the capacity of the muscle fibers to maintain intracellular calcium homeostasis. 
That is, endogenous calcium buffering, sequestration and extrusion pathways (4), coupled 
with a rapid membrane repair mechanism (2), might enable the muscle fibers to maintain 
normal levels of intracellular calcium as long as one of the calcium entry pathways is 
blocked. However, when calcium entry is occurring through both SAC and membrane 
lesions, the capacity of the calcium removal mechanisms might be exceeded, resulting in 
a calcium-induced force deficit. Another possibility is that the majority of sarcolemmal 
lesions repaired by P188 were a result of SAC activity. In this case, inhibition of SAC by 
streptomycin or repair of sarcolemmal lesions by P188 would be sufficient to rescue the 
muscle, and the combination of the two would not yield a pronounced improvement. 
Finally, we cannot exclude the possibility that P188 also acts as an inhibitor of SAC. 
Using an isolated lumbrical muscle preparation, we have demonstrated for the 
first time that P188, a membrane sealing poloxamer, is effective in the reduction of 
contraction-induced force deficits in a whole mdx skeletal muscle. This observation 
supports the interpretation that the contractions cause sarcolemmal lesions that permit the 
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entry of extracellular calcium into muscle fibers. These results provide the basis for 
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Fig 3.1. Lumbrical muscle from the 3rd digit of the forepaw of a mouse. (A) WT muscle 
is shown beside a 30G hypodermic needle. (B) Hematoxylin and eosin stained cross-
section of a WT lumbrical muscle. Muscles typically consist of 200-250 fibers and are 
approximately 300 μm in diameter. (C) mdx muscle. Dystrophic features include presence 
of central nuclei and mononuclear cell infiltration. All scale bars are 200μm and panels B 

































Fig 3.2.  Force production of WT and mdx lumbrical muscles. (A) Example records of 
isometric force production. For clarity, only records of the first (1) and last (20) isometric 
contractions are shown. (B) Force production of WT (n=6) and mdx (n=8) lumbrical 
muscles during a protocol of 20 isometric contractions in normal Tyrode solution. Break 
in x-axis denotes a 10-minute rest period. A two-way ANOVA was performed to 
determine effects of dystrophin deficiency and contraction number on the force deficit. # 






















































Fig 3.3. Force production of mdx and WT lumbrical muscles at the end of 20 isometric 
contractions. A one-way ANOVA was performed followed by 2 separate post hoc 
comparisons between groups. In the first comparison, all groups were compared against 
the untreated mdx group (Power > 0.8). In the second, all groups were compared against 
the WT group (Power > 0.8).  ∗ and # indicate difference from WT and untreated mdx 
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Fluorescent indicators reveal no evidence of sarcolemmal lesions in whole skeletal 
muscles during lengthening contractions 
 
Abstract 
After a protocol of lengthening contractions, leakage of cytosolic enzymes and 
influx of membrane-impermeable dyes have been used as evidence of lesions in the 
sarcolemma. The causes of these contraction-induced lesions cannot be established 
through results from enzyme leakage and dye uptake assays because of the limited 
temporal resolution that these techniques provide. In the present study, we describe the 
use of two fluorescence-based methods capable of reporting membrane lesions with high 
temporal resolution. Utilizing these improved assays, we sought to determine whether 
mechanical stress alone is sufficient to produce contraction-induced sarcolemmal lesions. 
Fluorescent dyes Fluo-4 and FM1-43 were applied to a very small whole skeletal muscle 
from the forepaw of the mouse and the fluorescence responses of both dyes were 
monitored during an acute protocol of 15 severe lengthening contractions. Analysis of 
fluorescence responses throughout the contraction protocol revealed no evidence of 
mechanically-induced lesions in the sarcolemma. Similar results were obtained from 
muscles that had an impaired membrane-repair mechanism. These results indicate that 
mechanical stresses associated with the lengthening contraction protocol, while severe 
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enough to cause a 30% force deficit, did not produce sarcolemmal lesions in the fibres of 
an intact skeletal muscle. This finding supports the idea that contraction-induced 
sarcolemmal lesions arise from a combination of biochemical as well as mechanical 
stressors, and that mechanical stress is not the direct cause of the contraction-induced 
lesions reported by dye-influx and/or enzyme-efflux assays. 
 
Introduction 
Daily activity and physical exercise subject muscles to considerable mechanical 
stress and changes in length (11). Muscles exposed to lengthening contractions frequently 
sustain force deficits that are associated with contraction-induced injury (9; 10). 
Immediately after an injurious contraction protocol, muscles exhibit disruptions to force 
generating structures (10; 26), a reduction in function of the excitation-contraction 
coupling system (36; 39), and  an increase in proteolytic activity (4). Sarcolemmal lesions 
are also associated with contraction-induced injury, inferred from the movement of 
bulky, membrane impermeable dyes and enzymes across the membrane (1; 12; 27). The 
contraction-induced lesions are thought to occur as a direct result of mechanical stress 
generated during contractile activity (1; 27; 33). The evidence for this interpretation is 
weakened by the low temporal resolution associated with dye-uptake and enzyme-efflux 
assays, which typically require substantial periods of contractile activity or incubation 
(~60-90min) (27; 34; 38). Prolonged contractile activity and/or incubation times (4; 15; 
42) result in an increase in the activity of proteases, phospholipases and reactive oxygen 
species, increasing the likelihood of their contribution to sarcolemmal disruptions (17). 
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Consequently, the lesions that are reported by these assays may be partially attributable to 
biochemical stressors. The purpose of the present study was to determine the direct effect 
of mechanical stress on contraction-induced membrane lesions. 
To minimize contributions from biochemical stressors, we utilized a short 
experimental protocol that consisted of 15 severe lengthening contractions performed 
over a period of 15 min. As traditional dye/enzyme membrane permeability assays do not 
allow the detection of membrane lesions over brief time periods, we employed alternative 
detection assays based on the fluorescent indicators Fluo-4 and FM1-43. Both indicators 
have been used previously to detect membrane breaches (2; 3; 22; 28). The fluorescent 
indicators were applied to a very small whole muscle preparation, the lumbrical muscle, 
obtained from the forepaw of the mouse (32). The lumbrical muscles were subjected to 
the protocol of lengthening contractions and the fluorescence emissions from both Fluo-4 
and FM1-43 were monitored. To amplify any effects of membrane lesions, the same 
contraction protocol was also performed on muscles that lack dysferlin, a protein that 
augments the membrane repair process (3; 24; 25). We hypothesized that during a 
protocol of lengthening contractions, fluorescence from both Fluo-4 and FM1-43 would 
increase, reflecting the presence of membrane lesions, and that the fluorescence increases 
would be greater in dysferlin-null muscle. 
 
Methods 
Specific-pathogen-free male wild-type (WT) C57BL/6 and dysferlin null mice 
(A/J, stock #000686) mice 8-12 months of age were obtained from the Jackson 
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Laboratory (Bar Harbor, ME). A/J mice exhibit a complete loss of dysferlin and display 
symptoms of progressive muscular dystrophy that includes elevated serum CK levels, 
myofibre degeneration and regeneration and muscle inflammation (20). References to 
muscles from A/J and wild-type mice will hereafter be termed dysf-null and WT muscles, 
respectively. Mice were housed in a specific-pathogen-free barrier facility at the 
University of Michigan. All experimental procedures were approved by the University of 
Michigan Committee on the Use and Care of Animals and in accordance with the Guide 
for the Care and Use of Laboratory Animals [DHHS Publication No. 85–23 (NIH), 
Revised 1985, Office of Science and Health Reports, Bethesda, MD 20892]. 
 
Operative Procedure 
Mice were anesthetized with an intraperitoneal injection of Avertin 
(tribromoethanol 400mg/kg). Supplemental doses of Avertin were administered as 
required to keep the mouse unresponsive to tactile stimuli.  The front paws were removed 
and the lumbrical (LMB) muscles dissected free from the third digit. The benefits of 
using LMB muscles as models to study contraction-induced injury have been discussed 
previously (13; 32). The mice were subsequently euthanized by an overdose of Avertin 
followed by a thoracotomy. Dissections were performed in a chilled bathing solution 
(approx. 8oC), composition (in mM): 137 NaCl, 11.9 NaHCO3, 5.0 KCl, 1.8 CaCl2, 0.5 
MgCl2, 0.4 NaH2PO4. The isolated LMB muscle was mounted horizontally in a custom-
fabricated chamber with the distal tendon attached to a force transducer (Aurora 
Scientific, Inc., modified Model 400A) and the proximal tendon to a servomotor (Aurora 
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Scientific, Inc., Model 318B). The ties were composed of 10-0 monofilament nylon 
suture. Bath temperature was maintained at 25oC and the chamber was perfused 
continuously with Tyrode solution, except during FM1-43 experiments where, instead of 
perfusion, the entire bath was changed every 5 minutes. The composition of the Tyrode 
solution was (in mM): 121 NaCl, 24 NaHCO3, 5.0 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 
NaH2PO4. For nominally calcium-free experiments, CaCl2 was omitted from the Tyrode 
solution and MgCl2 was increased to 2.3 mM to maintain the concentration of divalent 
cations. A pH of 7.3 was maintained by bubbling with a 95%/5% O2/CO2 mixture.  
 
Protocol for inducing injury 
Muscles were stimulated electrically by current passed between two platinum 
plate electrodes. The constant-current stimulation pulses were 0.5 ms in duration and 
their magnitude was adjusted to elicit a maximum twitch response. Optimum length (Lo) 
of each muscle was determined by adjusting muscle length until maximum twitch force 
was attained. LMB muscles are sufficiently small that individual fibres can be discerned, 
allowing the length of muscle fibres (Lf) to be determined visually when the muscle was 
at Lo. To achieve a maximum isometric tetanic contraction, the muscle was stimulated 
with supramaximal intensity and frequency using pulses of alternating polarity. The 
stimulation duration for each lengthening contraction was 700 ms and a stretch at 30% Lf 
was applied 300 ms after the start of stimulation. The muscle was lengthened at 0.75 Lf/s, 
causing the peak of the stretch to coincide with the end of tetanic stimulation, 400 ms 
after the initiation of the stretch. The lengthening contractions were applied at 1 minute 
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intervals and the protocol consisted of 15 such contractions. We have shown previously 
that LMB muscles subjected to a similar protocol of isometric contractions do not exhibit 
fatigue or deterioration (32). To facilitate comparisons among groups of muscles that 
varied in mass, the absolute isometric force of each muscle during the contraction 
protocol was normalized to the maximum isometric force (Po) produced by the muscle 
during the 15-contraction protocol. 
 
FM1-43 and Fluo-4 as indicators of membrane breaches 
Both FM1-43 and Fluo-4 have been demonstrated to be reliable indicators of 
membrane breaches, albeit through distinct, independent mechanisms (14; 37). FM1-43 is 
a membrane-impermeable dye that fluoresces when partitioned into membranes (14).  In 
the presence of membrane breaches, the fluorescence intensity of FM1-43 increases 
many-fold as the dye enters the cell and rapidly partitions into intracellular membrane 
surfaces (3; 28). Fluo-4 is a highly sensitive Ca2+ indicator (Kd ~ 345nm) (16) that 
exhibits a ~100-fold enhancement in fluorescence upon binding with Ca2+ (19). Cells 
loaded with Fluo indicators respond dramatically to breaches in the membrane (2; 22), as 
Ca2+ from the extracellular space enters the cell, driven by a concentration gradient of 
18,000:1 (40).  
 
Measurements of fluorescence from FM1-43 and Fluo-4 
A buffer containing FM1-43 (2.5 μM) was prepared by dissolving the dye in 
freshly-oxygenated Tyrodes solution. The prohibitive cost of FM1-43 rendered its 
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continuous perfusion unfeasible. Instead, the FM1-43 buffer was replaced every 5 
minutes with a new preparation from freshly-oxygenated Tyrodes solution. Prior to the 
lengthening contraction protocol, fluorescence measurements were made to ensure that 
muscle had achieved equilibrium with the FM1-43 buffer. Fluorescence was elicited by 
epi-illumination from a 75 W xenon lamp and detected using a photomultiplier tube 
(Photon Technology International, model R1527 PMT). The wavelengths for excitation 
were centred at 479 nm (bandwidth 2 nm), selected using a diffraction grating 
monochrometer (PTI, model Deltascan 4000). The emitted fluorescence passed through a 
longpass filter (520 nm) before reaching the photomultiplier tube. During the lengthening 
contraction protocol, fluorescence measurements were taken 30 s after each contraction at 
a sample rate of 100 measurements per second for 5 s. The median of the 500 
measurements was taken to be the fluorescence value after each lengthening contraction.  
For the Ca2+-sensing experiments, LMB muscles were loaded simultaneously with 
Fluo-4 and Fura-PE3 (Teflabs, Austin, TX). Both dyes were loaded in membrane-
permeant acetoxymethyl ester (AM) forms at 15μM and 25°C for 30 min. Pluronic F-127 
(0.01 % w/v; Molecular Probes) was used as a dispersing agent. The combined use of 
Fura-PE3 and Fluo-4 was employed because the fluorescence measured from non-
ratioable dyes, such as Fluo-4, is susceptible to fluctuations not related to [Ca2+], such as 
those caused by dye leakage and loading non-uniformity. In contrast, dual-wavelength 
excitation of ratioable indicators such as Fura-PE3 produces a response that is much less 
sensitive to fluctuations in dye concentration (30; 31). Fura-PE3, however, becomes less 
reliable upon commencement of the contraction protocol, as its excitation spectrum 
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overlaps that of NADH (7), an intracellular coenzyme that fluctuates in concentration 
during muscle activity (23). To overcome the inherent limitations of Fluo-4 and Fura-
PE3, a linear scaling algorithm was developed that used ratiometric measurements of 
Fura-PE3 made during periods of muscle inactivity, to transform the signal from Fluo-4 
into a pseudo-ratio signal. This was done by adjusting the Fluo-4 signal using two 
ratiometric measurements of Fura-PE3, one taken before the lengthening contraction 
protocol and the other 5 minutes after (see Fig 4.1). 
Fluorescence of Fura-PE3 was achieved by exciting the muscle with two 
alternating wavelengths set by diffraction grating monochromators centred at 375 and 
340 nm (bandwidth 4 nm). The emitted fluorescence was passed through a 510 nm 
bandpass filter (bandwidth 40 nm) and fluorescence was measured at a rate of 10 
wavelength pairs per second. For Fluo-4 measurements, an excitation wavelength centred 
at 493 nm (bandwidth 4 nm) was used and the emitted fluorescence passed through a 535 
nm bandpass filter (bandwidth 40 nm) and was sampled at 100 measurements per second. 
The Fluo-4 signal was then processed using the standard median filter in MATLAB® 
(Mathworks, Natick, MA) set to a window size of 17 data points. To quantify the 
fluorescence intensity of Fluo-4 after each lengthening contraction, the pseudo-ratio 
signal from Fluo-4 was integrated over a period of 59 s, starting 300 ms after cessation of 
electrical stimulation (see Fig 4.1). The 300 ms delay was incorporated to minimize 
movement-associated artefacts in the fluorescence response and to allow time for both the  
[Ca2+] and rate of change of [Ca2+] to fall to levels that could be reported by Fluo-4 with 
minimal distortion (16). 
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Statistics 
 Data are presented as a mean value ± SEM. Statistical analyses were performed 
using analysis of variance (ANOVA) with the level of significance set a priori at P < 




The absolute Po of dysf-null muscles (10.9 ± 0.8 mN, n=5) was less than that of 
WT muscles (14.7 ± 0.9 mN, n=7). When subjected to a protocol of 15 lengthening 
contractions, WT and dysf-null muscles exhibited final force deficits of 30 ± 4 % and 23 
± 3 %, respectively (Fig 4.2). The magnitude of force deficit was unchanged after a 10 
min recovery period (data not shown), indicating that the force deficits observed were not 
influenced by muscle fatigue, but rather were due to contraction-induced injury (8). 
Comparisons between dysf-null and WT muscles at individual contraction intervals 
revealed differences between the two genotypes for each response after the 9th 
contraction (Fig 4.2).  
  
FM1-43 intensity during lengthening contraction protocol. 
Throughout the lengthening contraction protocol, the fluorescence intensity of 
FM1-43 in dysf-null muscles was not different from WT muscles (Fig 4.3). To serve as a 
positive control, lengthening contractions were also carried out in the presence of 
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phospholipase A2 (15μg/ml, Sigma), a myotoxin found in bee venom that disrupts the 
integrity of the sarcolemma (18). Muscles exposed to phospholipase A2 exhibited an 
increase in FM1-43 signal intensity throughout the progression of the lengthening 
contraction protocol (Fig 4.3). 
 
Concentration of intracellular calcium ([Ca2+]i ) from measurements of Fluo-4 
The time-integral of the pseudo-ratio signal of Fluo-4 after each lengthening 
contraction (see Methods) yielded the intercontraction [Ca2+]i, hereafter abbreviated as 
[Ca2+]int. In both WT and dysf-null muscles, the [Ca2+]int remained constant throughout 
the contraction protocol (Fig 4.4). Although [Ca2+]int was unchanged in both mouse 
models, the [Ca2+]int was consistently greater in dysf-null muscles (Fig 4.4). The [Ca2+]int 




After contractile activity, dye-influx and enzyme-efflux assays indicate an 
increase in membrane permeability of skeletal muscles under both in vivo (6; 27) and in 
vitro (38) conditions. The increase in membrane permeability reported by these assays 
arises from either mechanical stress, biochemical processes (17), or a combination the 
two. Typical dye-influx and enzyme-efflux assays require substantial periods of 
contractile activity or incubation with the dye (27; 34; 38). Consequently, these tests 
cannot differentiate between membrane breaches caused directly by mechanical stress 
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and those caused by biochemical processes. We subjected whole skeletal muscles from 
both WT and dysf-null mice to a brief protocol of injury-inducing lengthening 
contractions and, using two independent fluorescence-based detection assays, monitored 
the muscles continuously for evidence of mechanically-induced membrane lesions. 
Contrary to our hypothesis, we found no evidence that membrane breaches were being 
formed during the protocol of lengthening contractions. 
 
Force deficits following the lengthening contraction protocol 
Compared with isometric contractions or passive stretches, lengthening 
contractions generate the greatest mechanical stress and ultrastructural damage to muscle 
(26) and are therefore most suitable for studying mechanically-induced lesions in the 
membrane. Our lengthening contraction protocol was deliberately limited to 15 minutes 
with ample time for recovery between contractions. These parameters ensured that 
changes in membrane permeability, if detected, would be attributable directly to 
mechanical stress and not membrane-targeting biochemical processes that are augmented 
by fatiguing protocols or extended incubation (4; 15; 42). The 30% force deficit elicited 
by our contraction protocol is either similar to (12), or greater than (38), the force deficits 
reported in traditional membrane permeability assays in which enzyme-efflux was 
detected. The similarity in force deficits indicates that absence of membrane lesions in 
the present study cannot be explained simply by inadequate levels of mechanical stress. 
   71
FM1-43 and Fluo-4 yield no evidence of membrane lesions 
FM1-43 is membrane-impermeant indicator that has been used previously to 
detect disruptions of the plasma membrane (3; 28).  Bansal et. al. demonstrated that a 
single laser-induced lesion in the sarcolemma of WT muscle fibres elicits a substantial 
increase in the fluorescence intensity of FM1-43 and that the increase is even more 
pronounced in dysf-null muscle fibres (3). When subjected to the present protocol of 
lengthening contractions, neither WT nor dysf-null muscles exhibited an increase FM1-43 
fluorescence (Fig 4.3), suggesting that contraction-induced membrane lesions were not 
present in either mouse model. In contrast, WT muscles exposed to phospholipase A2 
sustained disruptions to the membrane that were clearly reported by FM1-43 (Fig 4.3).  
To obtain an additional, independent assessment of sarcolemmal integrity, a 
further series of experiments was performed utilizing Fluo-4, a sensitive Ca2+ indicator 
used routinely to measure [Ca2+]i (21; 41). Fluo indicators have been adapted successfully 
for the detection of membrane lesions, as they report effectively the increase in [Ca2+]i 
that results from membrane breaches (2; 22). In the present study, the [Ca2+]int of both 
WT and dysf-null muscles remained constant throughout the lengthening contraction 
protocol (Fig 4.4), providing additional support for the conclusion that membrane lesions 
were not being formed as a direct consequence of high stress levels. Although [Ca2+]int 
remained unchanged in both mouse models, the [Ca2+]int was consistently greater in dysf-
null muscles (Fig 4.4). The larger [Ca2+]int observed in dysf-null muscle could be due to a 
less rapid removal of cytosolic Ca2+ by endogenous Ca2+ sequestering systems, or by a 
steady leakage of extracellular Ca2+ into the muscle fibres. To distinguish between these 
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two possibilities, lengthening contractions were performed on dysf-null muscles in a 
Ca2+-free buffer. The [Ca2+]int response was unaltered by the removal of Ca2+ from the 
bathing medium, indicating that the elevated [Ca2+]int observed in dysf-null muscle was 
not attributable to entry of extracellular Ca2+. We postulate that the elevated [Ca2+]int 
observed in dysf-null results from genetic differences between the BL/6 and A/J mice 
(29), or alternatively, that the lack of dysferlin affects the post-activation Ca2+ 
sequestering processes in the A/J mice. 
 
Role of mechanical stress in the formation of sarcolemmal lesions 
Despite sustaining a post-protocol force deficit of ~30%, LMB muscles did not 
show any evidence of sarcolemmal lesions, suggesting that the sarcolemma was able to 
tolerate mechanical stress relatively well. The resilience of the sarcolemma to mechanical 
stress may be attributable to protective mechanisms such as lateral force transmission 
pathways (5) and indentations (35) in the membrane that help to minimize damage to the 
membrane during contractile activity. These protective mechanisms, however, become 
inadequate during prolonged contractile activity or incubation, as evidenced by the 
movement of membrane-impermeant dyes and enzymes across the sarcolemma (1; 12; 
27). These sarcolemmal breaches occurred despite inducing force deficits that were only 
half as large as those of the present study (1; 12). These observations, coupled with the 
fact that deleterious membrane-targeting processes are augmented by prolonged 
contractile activity or incubation (4; 15; 42), suggest that membrane-targeting processes 
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such as phospholipases, calpains and ROS may play a more significant role in the 
formation of contraction-induced sarcolemmal lesions than previously anticipated. 
Our results suggest that mechanical stress alone, when applied within 
physiological boundaries, is insufficient to elicit sarcolemmal lesions in a whole skeletal 
muscle. Instead, sarcolemmal lesions are likely to be formed through a combination of 
biochemical and mechanical stressors. The present study offers new insights into the 
relationship between mechanical stress and sarcolemmal disruption, contributing to the 
understanding of the initial events that occur in contraction-induced injury.  
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Fig 4.1. Measurements from ratioable indicator Fura-PE3 transform Fluo-4 fluorescence 
into a pseudo-ratio signal. The motivation for generating a pseudo-ratio signal is 
described in METHODS. (A) LMB muscle loaded with Fluo-4/Fura-PE3 and subjected 
to a single lengthening contraction. Images were acquired by an electron-multiplying 
CCD camera (Photometrics® QuantEM:512SC) and used solely for visualization 
purposes. (B) Typical experimental record of Fluo-4 fluorescence intensity depicting a 
gradual decline due to Ca2+-independent factors such as dye leakage or 
compartmentalization into intracellular organelles. (C) The Fluo-4 signal is anchored to 
an initial ratio measurement from Fura-PE3 (●). Note that the gradual decline in Fluo-4 
intensity remains uncorrected. (D) The Fluo-4 signal is further transformed using a Fura-
PE3 ratio measurement (×) taken 5 min after the contraction protocol. This was done by 
multiplying the entire Fluo-4 signal with a linear scaling array. The result is a 
transformation of the Fluo-4 signal into pseudo-ratio signal. Note the correction in the 
decline of Fluo-4 intensity. (E) Close-up of 1st peak depicting the area used to quantify 
intracellular [Ca2+]. The area (shaded) was obtained by computing the time-integral 
bounded by the dashed and solid lines. 
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Fig 4.2.  Force production of WT and dysf-null lumbrical muscles. Gradual decline in 
force production of muscles from both mouse models during a protocol of 15 lengthening 
contractions. * indicates difference between WT and dysf-null muscles at matching time 
points (P < 0.05). 
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Fig 4.3. Normalized fluorescence intensities of FM1-43 during progression of 
lengthening contraction protocol. Fluorescence intensity of FM1-43 was captured 30s 
after each lengthening contraction in WT and dysf-null muscle. ANOVA revealed no 
differences between genotypes. As a positive control, the lengthening contraction 
protocol was also carried out in the presence of phospholipase A2, which causes 
disruptions in the membrane. 
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Fig 4.4. Intercontraction [Ca2+]i ([Ca2+]int) during progression of lengthening contraction 
protocol. Responses were quantified by computing the time-integral of the pseudo-ratio 
signal from Fluo-4 (see Fig 4.1). Data from experiments with calcium omitted from the 
buffer are denoted as “0 Ca2+”. A three-way ANOVA was performed to determine effects 
of (1) dysferlin deficiency, (2) contraction number and (3) calcium in extracellular buffer 
on the [Ca2+]int. Only dysferlin deficiency affected [Ca2+]int (P < 0.05). 
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Summary and Conclusion 
Overview 
This overall purpose of this dissertation was to elucidate the contribution of 
membrane lesions to contraction-induced injuries in skeletal muscles. Prior to the 
research presented in this dissertation, the conditions that lead to the formation of 
sarcolemmal lesions were seldom characterized in an adequate manner. The lack of 
experimental data on contraction-induced sarcolemmal lesions was due in part to the 
limited number of skeletal muscle models that permitted lesions of membranes to be 
studied reliably. The techniques required for the study of membrane lesions, such as the 
use of fluorescence microscopy, membrane-staining dyes and large macromolecular 
compounds, could only be applied reliably to intact single muscle fiber preparations. On 
close scrutiny, we did not find the single muscle fiber preparation to be satisfactory 
model for the study of contraction-induced sarcolemmal lesions because the behavior of a 
single muscle fiber, existing without lateral connections to adjacent muscle fibers, was 
unlikely to represent accurately the function of single fibers in a whole muscle.  
Accordingly, we developed a micro-sized whole muscle model utilizing the 
lumbrical muscle (LMB) from the forepaw of the mouse. The exceedingly small LMB 
muscle retains some of the diffusion benefits and visualization advantages normally 
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accorded to single muscle fiber preparations, while still maintaining a more accurate 
representation of in vivo whole muscle function. The remainder of this chapter will 
highlight the significant findings that arose from utilizing LMB muscles to study 
contraction-induced injury, as well as discuss the future direction of membrane-based 
muscle research. 
  
LMB muscles as models to study contraction-induced injury (Chapter 2) 
The goal of this study was to assess the potential of LMB muscles as models to 
study contractile activity. When subjected to 900 isometric contractions, LMB muscles 
remained viable throughout the 30 min contraction protocol and did not exhibit signs of 
fatigue or deterioration. This level of stability and robustness has never been 
demonstrated in any in vitro muscle preparation; conventional whole muscle models 
exhibit signs of fatigue even under less demanding contraction protocols (3). When 
subjected to an injurious protocol of repetitive lengthening contractions, LMB muscles 
showed signs of injury to individual fibers that could be visualized effectively and 
quantified by the use of appropriate dyes. The ability to visualize the injury in such detail 
immediately after a lengthening contraction protocol has never been achieved in an in 
vitro whole muscle preparation. Overall, LMB muscles were found to be (i) fluorescence-
capable, (ii) sufficiently small to promote the diffusion of dyes and macromolecules (3), 
and (iii) stable even under severe metabolic demands. These features render the LMB 
muscle an attractive and reliable model to study contractile activity in vitro. 
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Membrane disruptions contribute to force deficits in dystrophic muscle (Chapter 3) 
Using the LMB muscle preparation, we investigated the extent to which 
sarcolemmal disruptions contributed to the post-contraction force deficits of dystrophic 
mice. Application of a membrane-patching polymer (P188) and stretch-activated channel 
inhibitor reduced, almost completely, the contraction-induced force deficits of dystrophic 
muscles. These findings reinforced the direct relationship between sarcolemmal 
disruption and muscle dysfunction, and demonstrated that sarcolemmal lesions and 
stretch-activated ion channels accounted for almost the entire force deficit observed in 
dystrophic muscle. The results obtained in this study raised the prospect of developing 
therapeutic strategies directed at membrane stabilization of dystrophin-deficient skeletal 
muscle fibers. 
 
No evidence of membrane lesions in wild-type muscle (Chapter 4) 
Based on the positive findings from the previous chapter, we sought to determine 
if similar contraction-induced lesions also occurred in wild-type muscle. A novel 
fluorescence-based assay was developed, capable of detecting sarcolemmal breaches in 
real time. Utilizing this assay, we subjected wild-type LMB muscles to an acute protocol 
of severe lengthening contractions and did not find evidence of membrane lesions. 
Similar results were also obtained when the assay was applied to muscles that lacked 
dysferlin, a protein that is required for membrane repair (1). Taken together, these results 
suggested that sarcolemmal lesions were not contributory factors to the contraction-
induced force deficits in wild-type muscle. 
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Conclusions and future research 
The research presented in this dissertation has utilized a membrane-based 
approach to understand contraction-induced injuries. We demonstrate that sarcolemmal 
lesions play an important role in the contraction-induced force deficit of dystrophic 
muscle, but do not appear to be as significant in wild-type muscle. Future research should 
be directed at elucidating the contribution of other cellular events to contraction-induced 
injuries, such as the role of reactive oxygen species and proteolytic enzyme activity. 
Given the unique features of a micro-sized muscle preparation, these events should 
continue to be studied in the LMB muscle model. In addition, the LMB muscle offers an 
exciting prospect of examining whole muscle function from novel perspectives, such as 
those offered by ultra-sensitive fluorescence microscopy (5), RNA interference (4) and 
fluorescent protein techniques (2). 
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